Literature DB >> 12776133

US FDA contemplates collection of pharmacogenomic data.

Jim Kling.   

Abstract

Mesh:

Year:  2003        PMID: 12776133     DOI: 10.1038/nbt0603-590a

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  4 in total

1.  Pharmacogenomics--how close/far are we to practising individualized medicine for children?

Authors:  Chor-Wing Sing; Ching-Lung Cheung; Ian C K Wong
Journal:  Br J Clin Pharmacol       Date:  2015-03       Impact factor: 4.335

2.  Lovastatin protects against cisplatin-induced hearing loss in mice.

Authors:  Katharine Fernandez; Katie K Spielbauer; Aaron Rusheen; Lizhen Wang; Tiffany G Baker; Stephen Eyles; Lisa L Cunningham
Journal:  Hear Res       Date:  2020-02-06       Impact factor: 3.208

Review 3.  Cancer pharmacogenomics in children: research initiatives and progress to date.

Authors:  Shahrad Rod Rassekh; Colin J D Ross; Bruce C Carleton; Michael R Hayden
Journal:  Paediatr Drugs       Date:  2013-04       Impact factor: 3.022

4.  Replication of TPMT and ABCC3 genetic variants highly associated with cisplatin-induced hearing loss in children.

Authors:  K Pussegoda; C J Ross; H Visscher; M Yazdanpanah; B Brooks; S R Rassekh; Y F Zada; M-P Dubé; B C Carleton; M R Hayden
Journal:  Clin Pharmacol Ther       Date:  2013-04-10       Impact factor: 6.875

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.